These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 12231598)

  • 1. Improving the effectiveness of routine prenatal screening for major congenital heart defects.
    Carvalho JS; Mavrides E; Shinebourne EA; Campbell S; Thilaganathan B
    Heart; 2002 Oct; 88(4):387-91. PubMed ID: 12231598
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Importance of "Guidelines for performing fetal cardiac scan" in prenatal screening for fetal congenital heart disease].
    Xu Y; Hu YL; Ru T; Gu Y; Yang Y; Dai CY
    Zhonghua Fu Chan Ke Za Zhi; 2009 Feb; 44(2):103-7. PubMed ID: 19570419
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The role of fetal nuchal translucency (NT) and ductus venosus blood flow (DV) in the detection of congenital heart defects].
    Baś-Budecka E; Perenc M; Sieroszewski P
    Ginekol Pol; 2010 Apr; 81(4):272-6. PubMed ID: 20476599
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ultrasound soft markers and fetal cardiac structural assessment at 11-14 weeks].
    Yang Y; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2014 Mar; 49(3):188-92. PubMed ID: 24820303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of fetal nuchal translucency and ductus venosus Doppler at 11-14 weeks of gestation in the detection of major congenital heart defects.
    Favre R; Cherif Y; Kohler M; Kohler A; Hunsinger MC; Bouffet N; Tanghe M; Cancellier M; Nisand I
    Ultrasound Obstet Gynecol; 2003 Mar; 21(3):239-43. PubMed ID: 12666217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early diagnosis of major cardiac defects in chromosomally normal fetuses with increased nuchal translucency.
    Zosmer N; Souter VL; Chan CS; Huggon IC; Nicolaides KH
    Br J Obstet Gynaecol; 1999 Aug; 106(8):829-33. PubMed ID: 10453834
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prenatal screening for congenital heart disease with four-chamber and outflow-tract views: a multicenter study.
    Oggè G; Gaglioti P; Maccanti S; Faggiano F; Todros T
    Ultrasound Obstet Gynecol; 2006 Nov; 28(6):779-84. PubMed ID: 17031872
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nuchal translucency measurement and congenital heart defects: modest association in low-risk pregnancies.
    Müller MA; Clur SA; Timmerman E; Bilardo CM
    Prenat Diagn; 2007 Feb; 27(2):164-9. PubMed ID: 17238215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early fetal ultrasound screening for major congenital heart defects without Doppler.
    García Fernández S; Arenas Ramirez J; Otero Chouza MT; Rodriguez-Vijande Alonso B; Llaneza Coto ÁP
    Eur J Obstet Gynecol Reprod Biol; 2019 Feb; 233():93-97. PubMed ID: 30580230
    [TBL] [Abstract][Full Text] [Related]  

  • 10. First-trimester fetal cardiac examination using spatiotemporal image correlation, tomographic ultrasound and color Doppler imaging for the diagnosis of complex congenital heart disease in high-risk patients.
    Turan S; Turan OM; Desai A; Harman CR; Baschat AA
    Ultrasound Obstet Gynecol; 2014 Nov; 44(5):562-7. PubMed ID: 24585667
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effectiveness of fetal cardiac screening for congenital heart disease using a combination of the four-chamber view and three-vessel view during the second trimester scan.
    Itsukaichi M; Serikawa T; Yoshihara K; Suzuki H; Haino K; Yamaguchi M; Enomoto T; ; Takakuwa K
    J Obstet Gynaecol Res; 2018 Jan; 44(1):49-53. PubMed ID: 29094487
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Using fetal nuchal translucency to screen for major congenital cardiac defects at 10-14 weeks of gestation: population based cohort study.
    Hyett J; Perdu M; Sharland G; Snijders R; Nicolaides KH
    BMJ; 1999 Jan; 318(7176):81-5. PubMed ID: 9880278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Routine ultrasound examination at 12 or 18 gestational weeks for prenatal detection of major congenital heart malformations? A randomised controlled trial comprising 36,299 fetuses.
    Westin M; Saltvedt S; Bergman G; Kublickas M; Almström H; Grunewald C; Valentin L
    BJOG; 2006 Jun; 113(6):675-82. PubMed ID: 16709210
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detailed screening for fetal anomalies and cardiac defects at the 11-13-week scan.
    Becker R; Wegner RD
    Ultrasound Obstet Gynecol; 2006 Jun; 27(6):613-8. PubMed ID: 16570262
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reliability of the first-trimester cardiac scan by ultrasound-trained obstetricians with high-frequency transabdominal probes in fetuses with increased nuchal translucency.
    Bellotti M; Fesslova V; De Gasperi C; Rognoni G; Bee V; Zucca I; Cappellini A; Bulfamante G; Lombardi CM
    Ultrasound Obstet Gynecol; 2010 Sep; 36(3):272-8. PubMed ID: 20499407
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fetal echocardiographic screening in twins for congenital heart diseases.
    Li H; Meng T; Shang T; Guan YP; Zhou WW; Yang G; Bi LH
    Chin Med J (Engl); 2007 Aug; 120(16):1391-4. PubMed ID: 17825165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Limitations of using first-trimester nuchal translucency measurement in routine screening for major congenital heart defects.
    Mavrides E; Cobian-Sanchez F; Tekay A; Moscoso G; Campbell S; Thilaganathan B; Carvalho JS
    Ultrasound Obstet Gynecol; 2001 Feb; 17(2):106-10. PubMed ID: 11251916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Why are congenital heart defects being missed?
    van Nisselrooij AEL; Teunissen AKK; Clur SA; Rozendaal L; Pajkrt E; Linskens IH; Rammeloo L; van Lith JMM; Blom NA; Haak MC
    Ultrasound Obstet Gynecol; 2020 Jun; 55(6):747-757. PubMed ID: 31131945
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fetal cardiac defects and increased nuchal translucency thickness: a prospective study.
    McAuliffe FM; Hornberger LK; Winsor S; Chitayat D; Chong K; Johnson JA
    Am J Obstet Gynecol; 2004 Oct; 191(4):1486-90. PubMed ID: 15507988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Screening for congenital heart defects by transabdominal ultrasound - role of early gestational screening and importance of operator training.
    Sarkola T; Ojala TH; Ulander VM; Jaeggi E; Pitkänen OM
    Acta Obstet Gynecol Scand; 2015 Mar; 94(3):231-5. PubMed ID: 25545405
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.